Description
ANTICOAGULATION IN CRITICAL CARE PATIENTS AND IN PATIENTS ON MECHANICAL CARDIOPULMONARY SUPPORT
- You cannot add another "Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer" to your cart. View cart
Article: ANTICOAGULATION IN CRITICAL CARE PATIENTS AND IN PATIENTS ON MECHANICAL CARDIOPULMONARY SUPPORT
€3.03
Related products
-
Article: Highlights in gynaecological cancers
€3.03 Add to cart -
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€3.03 Add to cart -
Article: Highlights in gynaecological cancers
€3.03 Add to cart -
1 year access Online Belgian Journal of Hematology (BJH)
€71.94 Add to cart
